The role of adipocytokines in colon cancer and adenomas

Journal of Medical Biochemistry

Volumn 33, Issue 2, 2013, Pages 135-142

  Tulubas, Feti ^a   Mete, Rafet ^a   Oznur, Meltem ^a   Topcu, Birol ^a  

^a NAMIK KEMAL UNIVERSITY   (Turkey)

Author keywords

Adiponectin; apelin; colon adenoma; colon cancer; visfatin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APELIN; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CANCER RISK; COLON ADENOMA; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MOLECULAR PATHOLOGY; PROTEIN FUNCTION;

EID: 84896822238     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/jomb-2013-0001     Document Type: Article

References (31)

1. Atamanalp SS, S?ent?rk F, G?rsan N, ?zt?rk G, Kantarc M, Yldrgan M et al. Endoscopic polypectomy: Outcomes of 467 cases in 20 years. Turk J Med Sci 2009; 39: 747-53.
2. Erarslan E, Turkay C, Koktener A, Koca C, Uz B, Bavbek N. Association of visceral fat accumulation and adipo-nectin levels with colorectal neoplasia. Dig Dis Sci 2009; 54: 862-8.
3. Farquharson AJ, Steele RJ, Carey FA, Drew JE. Novel multiplex method to assess insulin, leptin and adipo-nectin regulation of inflammatory cytokines associated with colon cancer. Mol Biol Rep 2012; 39: 5727-36.
4. Tudek B, Speina E. Oxidatively damaged DNA and its repair in colon carcinogenesis. Mutat Res 2012; 736: 82-92.
5. Be}arevi} M, Seferovi} J, Ignjatovi} S, Singh S, Majki}-Singh N. Adiponectin non-esterified fatty acids and antiphospholipid antibodies in type II diabetes mellitus. Journal of Medical Biochemistry 2012; 31: 199-204.
6. Gulcelik MA, Colakoglu K, Dincer H, Dogan L, Yeni-dogan E, Gulcelik NE. Associations between adiponectin and two different cancers: Breast and colon. Asian Pac J Cancer Prev 2012; 13: 395-8.
7. Canoru? N, E. K, Turhanolu DA, ?zmen S?, Og?n C, Kaplan A. Plasma resistin and leptin levels in overweight and lean patients with rheumatoid arthritis. Turk J Med Sci 2009; 39: 447-51.
8. Gonullu G, Kahraman H, Bedir A, Bektas A, Yucel I. Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis 2010; 25: 205-12.
9. Heo K, Kim YH, Sung HJ, Li HY, Yoo CW, Kim JY, et al. Hypoxia-induced up-regulation of apelin is associated with a poor prognosis in oral squamous cell carcinoma patients. Oral Oncol 2012; 48: 500-6.
10. Dalamaga M, Archondakis S, Sotiropoulos G, Kar ma-niolas K, Pelekanos N, Papadavid E, et al. Could serum visfatin be a potential biomarker for postmenopausal breast cancer Maturitas 2012; 71: 301-8.
11. Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: A systematic review. Br J Cancer 2006; 94: 1221-5.
12. Moon HS, Liu X, Nagel JM, Chamberland JP, Diako-poulos KN, Brinkoetter MT, et al. Salutary effects of adiponectin on colon cancer: In vivo and in vitro studies in mice. Gut 2012.
13. Fujisawa T, Endo H, Tomimoto A, Sugiyama M, Taka-hashi H, Saito S, et al. Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 2008; 57: 1531-8.
14. Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, Jang SH, et al. Adiponectin represses colon cancer cell proliferation via AdipoR1-and-R2-mediated AMPK activation. Mol Endo crinol 2010; 24: 1441-52.
15. Lukanova A, Soderberg S, Kaaks R, Jellum E, Stattin P. Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 401-2.
16. Stocks T, Lukanova A, Johansson M, Rinaldi S, Palmqvist R, Hallmans G, et al. Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond) 2008; 32: 304-14.
17. Kumor A, Daniel P, Pietruczuk M, Malecka-Panas E. Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis 2009; 24: 275-81.
18. Nakajima TE, Yamada Y, Hamano T, Furuta K, Matsuda T, Fujita S, et al. Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal ade noma, and resistin and visfatin for colorectal cancer. Cancer Sci 2010; 101: 1286-91.
19. Nishihara T, Baba M, Matsuda M, Inoue M, Nishizawa Y, Fukuhara A, et al. Adiponectin deficiency enhances colo-rectal carcinogenesis and liver tumor formation induced by azoxymethane in mice. World J Gastroenterol 2008; 14: 6473-80.
20. Stattin P, Lukanova A, Biessy C, Soderberg S, Palmqvist R, Kaaks R, et al. Obesity and colon cancer: Does leptin provide a link Int J Cancer 2004; 109: 149-52.
21. Tessitore L, Vizio B, Jenkins O, De Stefano I, Ritossa C, Argiles JM, et al. Leptin expression in colorectal and breast cancer patients. Int J Mol Med 2000; 5: 421-6.
22. Salageanu A, Tucureanu C, Lerescu L, Caras I, Pitica R, Gangura G, et al. Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life 2010; 3: 416-20.
23. Wagsater D, Mumtaz M, Lofgren S, Hugander A, Dim-berg J. Resistin in human colorectal cancer: Increased expression independently of resistin promoter-420C G genotype. Cancer Invest 2008; 26: 1008-14.
24. Sun CA, Wu MH, Chu CH, Chou YC, Hsu GC, Yang T, et al. Adipocytokine resistin and breast cancer risk. Breast Cancer Res Treat 2010; 123: 869-76.
25. Sorli SC, Le Gonidec S, Knibiehler B, Audigier Y. Apelin is a potent activator of tumour neoangiogenesis. Onco-gene 2007; 26: 7692-9.
26. Berta J, Kenessey I, Dobos J, Tovari J, Klepetko W, Jan Ankersmit H, et al. Apelin expression in human nonsmall cell lung cancer: Role in angiogenesis and prognosis. J Thorac Oncol 2010; 5: 1120-9.
27. Kasai A, Shintani N, Kato H, Matsuda S, Gomi F, Haba R, et al. Retardation of retinal vascular development in apelin-deficient mice. Arterioscler Thromb Vasc Biol 2008; 28: 1717-22.
28. Carpene C, Dray C, Attane C, Valet P, Portillo MP, Chur ruca I, et al. Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem 2007; 63: 359-73.
29. Yener S, Comlekci A, Yuksel F, Sevinc A, Ertilav S, Yesil S. Traditional and novel cardiovascular risk factors in nonfunctioning adrenal adenomas. Eur J Intern Med 2012; 23: 83-7.
30. Tilg H, Moschen AR. Role of adiponectin and PBEF/visfatin as regulators of inflammation: Involvement in obe si tyassociated diseases. Clin Sci (Lond) 2008; 114: 275-88.
31. Kim JG, Kim EO, Jeong BR, Min YJ, Park JW, Kim ES, et al. Visfatin stimulates proliferation of MCF-7 human breast cancer cells. Mol Cells 2010; 30: 341-5.